Please use this identifier to cite or link to this item:
http://dspace.dtu.ac.in:8080/jspui/handle/repository/17245
Title: | AARTI DRUGS LTD. FINANCIAL ANALYSIS AND PROPOSED ACQUISITION |
Authors: | DABODIYA, VIVEK |
Keywords: | DRUGS LTD CASH FLOW MARKETING |
Issue Date: | May-2016 |
Series/Report no.: | TD-2213; |
Abstract: | The Valuation report on Aarti Drugs LTD. is done keeping in mind a Value Equity philosophy, which is based on the belief that all successful investing should thoughtfully weigh two important attributes of a stock: price and prospects. Since some value managers tend to focus almost exclusively on stock price, they often underestimate the importance of prospects. However, we believe a company’s prospective ability to generate high cash flow returns on capital will strongly influence investment success. In our view, using a strong valuation discipline to purchase well-positioned, cash generating businesses run by shareholder-oriented management teams is the best formula for long-term portfolio performance. |
URI: | http://dspace.dtu.ac.in:8080/jspui/handle/repository/17245 |
Appears in Collections: | MBA |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
VivekDabodiya final.pdf | 941.03 kB | Adobe PDF | View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.